RT Journal Article
SR Electronic
A1 Vinall, Maria
T1 SELECT-LV
JF MD Conference Express
YR 2015
FD SAGE Publications
VO 15
IS 12
SP 8
OP 9
DO 10.1177/1559897715593728
UL http://mdc.sagepub.com/content/15/12/8.abstract
AB The SELECT-LV trial shows that direct, wireless endocardial left ventricular pacing for cardiac resynchronization therapy is feasible and results in significant reductions in QRS duration, synchronous left ventricular stimulation, evidence of electrical and structural remodeling, and improvement in left ventricular ejection fraction. There is no evidence of pericardial tamponade, and there are few procedural adverse events.